This mini-episode is part of our Inside The Story series, where we highlight some of The Lever’s original reporting and speak with the journalists who wrote the story. Frank Cappello speaks with Andrew Perez who details their new story published by The Lever:“Pfizer recently made headlines for hiking prices on roughly 100 drugs in the United States, shortly after the company announced plans to quadruple the price of its COVID-19 vaccine. Now, the pharmaceutical giant is paying news outlets to tell a different story — a fawning tale about how the company has been altruistically working to expand access to its products overseas.”To read the full story, click here.If you enjoyed this story and want to support independent journalism, you can go to LeverNews.com to subscribe to our free newsletter or become a paid supporter.